Advances in prognostic models for osteosarcoma risk

被引:2
|
作者
Yao, Yi [1 ,2 ]
Wang, Dapeng [1 ]
Zheng, Li [1 ,2 ,4 ]
Zhao, Jinmin [1 ,2 ,3 ]
Tan, Manli [1 ,2 ,4 ]
机构
[1] Guangxi Med Univ, Guangxi Engn Ctr Biomed Mat Tissue & Organ Regene, Affiliated Hosp 1, Nanning 530021, Peoples R China
[2] Guangxi Med Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Regenerat Med & Med Bioreso, Nanning 530021, Peoples R China
[3] Guangxi Med Univ, Dept Orthoped, Affiliated Hosp 1, Nanning 530021, Peoples R China
[4] Guangxi Med Univ, Life Sci Inst, Nanning 530021, Peoples R China
基金
中国国家自然科学基金;
关键词
Osteosarcoma; Risk -prognosis model; TUMOR-SUPPRESSOR; CELL-PROLIFERATION; OVARIAN CANCERS; DNA METHYLATION; DOWN-REGULATION; UP-REGULATION; EXPRESSION; PROTEIN; INVASION; RECEPTORS;
D O I
10.1016/j.heliyon.2024.e28493
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The risk prognosis model is a statistical model that uses a set of features to predict whether an individual will develop a specific disease or clinical outcome. It can be used in clinical practice to stratify disease severity and assess risk or prognosis. With the advancement of large-scale secondgeneration sequencing technology, along Prognosis models for osteosarcoma are increasingly being developed as large-scale second-generation sequencing technology advances and clinical and biological data becomes more abundant. This expansion greatly increases the number of prognostic models and candidate genes suitable for clinical use. This article will present the predictive effects and reliability of various prognosis models, serving as a reference for their evaluation and application.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Advances of Osteosarcoma Models for Drug Discovery and Precision Medicine
    Tan, Linyun
    Wang, Yitian
    Hu, Xin
    Du, Guifeng
    Tang, Xiaodi
    Min, Li
    BIOMOLECULES, 2023, 13 (09)
  • [2] Establishment of a prognostic risk model for osteosarcoma and mechanistic investigation
    Jiang, Hongyuan
    Zhao, Xuliang
    Zang, Jinhui
    Wang, Ruijiao
    Gao, Jiake
    Chen, Jinli
    Yu, Tengbo
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [3] Advances in osteosarcoma
    Whelan, J
    CANCER AND THE ADOLESCENT, SECOND EDITION, 2005, : 113 - 120
  • [4] Advances in Osteosarcoma
    Isidora Panez-Toro
    Javier Muñoz-García
    Jorge W. Vargas-Franco
    Axelle Renodon-Cornière
    Marie-Françoise Heymann
    Frédéric Lézot
    Dominique Heymann
    Current Osteoporosis Reports, 2023, 21 : 330 - 343
  • [5] Advances in Osteosarcoma
    Panez-Toro, Isidora
    Munoz-Garcia, Javier W.
    Vargas-Franco, Jorge
    Renodon-Corniere, Axelle
    Heymann, Marie-Francoise
    Lezot, Frederic
    Heymann, Dominique
    CURRENT OSTEOPOROSIS REPORTS, 2023, 21 (04) : 330 - 343
  • [6] Multimodal prognostic models and recent therapeutic advances
    Minervini, Andrea
    Mari, Andrea
    LANCET DIGITAL HEALTH, 2023, 5 (08): : E482 - E483
  • [7] A four-lncRNA risk signature for prognostic prediction of osteosarcoma
    Liu, Huanlong
    Chen, Chao
    Liu, Long
    Wang, Zengtao
    FRONTIERS IN GENETICS, 2023, 13
  • [8] Advances on immunotherapy for osteosarcoma
    Yu, Shengnan
    Yao, Xudong
    MOLECULAR CANCER, 2024, 23 (01)
  • [9] Surgical Advances in Osteosarcoma
    Brookes, Marcus J.
    Chan, Corey D.
    Baljer, Bence
    Wimalagunaratna, Sachin
    Crowley, Timothy P.
    Ragbir, Maniram
    Irwin, Alistair
    Gamie, Zakareya
    Beckingsale, Thomas
    Ghosh, Kanishka M.
    Rankin, Kenneth S.
    CANCERS, 2021, 13 (03) : 1 - 26
  • [10] Recent advances in osteosarcoma
    Botter, Sander M.
    Neri, Dario
    Fuchs, Bruno
    CURRENT OPINION IN PHARMACOLOGY, 2014, 16 : 15 - 23